Gina Consylman
2021 - Ironwood Pharmaceuticals
In 2021, Gina Consylman earned a total compensation of $2.8M as Former Senior Vice President, Chief Financial Officer at Ironwood Pharmaceuticals, a 13% increase compared to previous year.
Compensation breakdown
| Salary | $264,265 |
|---|---|
| Stock Awards | $2,519,901 |
| Other | $8,714 |
| Total | $2,792,880 |
Consylman received $2.5M in stock awards, accounting for 90% of the total pay in 2021.
Consylman also received $264.3K in salary and $8.7K in other compensation.
Rankings
In 2021, Gina Consylman's compensation ranked 4,712th out of 12,405 executives tracked by ExecPay. In other words, Consylman earned more than 62.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,712 out of 12,405 | 62nd |
Division Manufacturing | 1,959 out of 5,494 | 64th |
Major group Chemicals And Allied Products | 821 out of 2,369 | 65th |
Industry group Drugs | 734 out of 2,090 | 65th |
Industry Pharmaceutical Preparations | 522 out of 1,537 | 66th |
Source: SEC filing on April 21, 2022.
Consylman's colleagues
We found six more compensation records of executives who worked with Gina Consylman at Ironwood Pharmaceuticals in 2021.
2021
Thomas McCourt
Ironwood Pharmaceuticals
Chief Executive Officer
2021
Jason Rickard
Ironwood Pharmaceuticals
Chief Operating Officer
2021
John Minardo
Ironwood Pharmaceuticals
Chief Legal Officer
2021
Michael Shetzline
Ironwood Pharmaceuticals
Chief Medical Officer
2021
Sravan Emany
Ironwood Pharmaceuticals
Chief Financial Officer
2021
Mark Mallon
Ironwood Pharmaceuticals
Chief Executive Officer
News
bluebird bio CEO Andrew Obenshain receives $9.3M in 2021
May 2, 2022
Ironwood Pharmaceuticals CEO Thomas McCourt's 2021 pay jumps 158% to $8.8M
April 21, 2022
Ironwood Pharmaceuticals CEO Mark Mallon's 2020 pay falls 32% to $6.8M
April 22, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019